Siemens Gets Fresh Shot At HIV Test Patent

Law360, Los Angeles (August 14, 2013, 9:35 PM EDT) -- A Siemens AG unit got a shot at taking back its patent for HIV test technology when a Massachusetts federal judge ruled Wednesday that the Patent Trial and Appeal Board had committed legal errors when it awarded the patent to Enzo Life Sciences Inc.

In 2006, the board — then known as the Board of Patent Appeals and Interferences — had found that Siemens Healthcare Diagnostics Inc.’s U.S. Patent Number 5,124,246 conflicted with Enzo’s application on the grounds that at least one of Enzo’s claims was...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.